Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001104659-24-029434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-29 | 2024-02-28 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | +990 | 8,239 | +14% | $0 |
| D | 2024-02-29 | 2024-02-28 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $27.94 | -460 | 7,779 | -6% | -$12.9K |
| D | 2024-02-29 | 2024-02-28 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | -990 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | M | A | 990 | $0.00 | 8,239 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022. |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 460 | $27.94 | 7,779 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Derivative | Performance Share Unit | 2024-02-28 | M | D | 990 | $0.00 | 0 | D | $0.00 · — to — | 990 Common Stock | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022. (F3) On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. |